Artelo Biosciences Raises $310,000 in 12% Bridge Notes From Vanquish and Boot

NodeGuardian · 2026-04-06T08:01:49+00:00

Artelo Biosciences secured $310,000 via two 12% bridge notes from Vanquish Funding Group and Boot Capital to support working capital. The notes, maturing on January 15, 2027, include various provisions and cover legal costs for Vanquish.

NodeGuardian

2026-04-06 08:01:49

Abstract generation in progress

Artelo Biosciences raised $310,000 through two 12% bridge notes from Vanquish Funding Group and Boot Capital to fund working capital. These notes mature on January 15, 2027, and include provisions for an original issue discount, default acceleration, and equity conversion options. Artelo Biosciences will also cover diligence and legal costs for Vanquish.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.